Chromadex Corp
CDXC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$624.26M
Close$
$-0.10
101.3% downside
Current Fair Value
101.3% downsideOvervalued by 101.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $624.26 Million |
|---|---|
| Enterprise Value | $626.34 Million |
| Earnings per Share | $0.22 |
| Beta | 2.21 |
| Outstanding Shares | 79,322,000 |
Return
| Return on Equity | 12.33% |
|---|---|
| Return on Assets | 9.42% |
| Return on Invested Capital | 5.54% |
Valuation & Multiples
| P/E Ratio | 15.75 |
|---|---|
| PEG | -12.54 |
| Price to Sales | - |
| Price to Book Ratio | 7.87 |
| Enterprise Value to Revenue | 10.99 |
| Enterprise Value to EBIT | 123.17 |
| Enterprise Value to Net Income | 61 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
March 4, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 4.52, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 4.5169▲ 23.00% |
|---|---|
| Total Calls | 94,800▼ 2.17% |
| Total Puts | 428,200▲ 3.08% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 46.44%▲ 6.10% |
|---|---|
| Total Invested | $162.31M▼ 20.76% |
| Investors Holding | 150▼ 24.00% |
About Chromadex Corp
117 employees
CEO: Robert Fried
ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solut...